UK markets close in 6 hours 8 minutes

Arcus Biosciences, Inc. (RCUS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
15.63+0.08 (+0.51%)
At close: 04:00PM EDT
15.63 -0.01 (-0.03%)
After hours: 04:06PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
117,000
117,000
112,000
383,000
78,000
Operating expenses
Research development
340,000
340,000
288,000
257,000
159,000
Selling general and administrative
117,000
117,000
104,000
72,000
43,000
Total operating expenses
457,000
457,000
392,000
329,000
202,000
Operating income or loss
-340,000
-340,000
-280,000
54,000
-124,000
Interest expense
2,000
2,000
2,000
0
0
Income before tax
-301,000
-301,000
-266,000
55,000
-123,000
Income tax expense
6,000
6,000
1,000
2,000
0
Income from continuing operations
-307,000
-307,000
-267,000
53,000
-123,000
Net income
-307,000
-307,000
-267,000
53,000
-123,000
Net income available to common shareholders
-307,000
-307,000
-267,000
53,000
-123,000
Basic EPS
-1.93
-4.15
-3.71
0.76
-2.24
Diluted EPS
-1.93
-4.15
-3.71
0.71
-2.24
Basic average shares
43,826
74,000
72,000
69,300
54,800
Diluted average shares
43,826
74,000
72,000
74,000
54,800